AINOS Inc.

AINOS Inc.https://investorshangout.com/AINOS-Inc-AIMDD-58306/en-usSun, 13 Sep 2026 14:19:01 GMTCopyright InvestorsHangout.comznewcar1: $AIMD 22% v3,0M c1.56 f20,011M H1.83 ML.63 lost the last Dhttps://investorshangout.com/post/view?id=6549382https://investorshangout.com/post/view?id=6549382Thu, 16 Mar 2023 22:16:20 GMTEmylers: AMARQ Financials 07/16/2014 06:39:38 Amarillo Biosciences, Inc. Period Ending Dec 31, 2013 Dec 31,https://investorshangout.com/post/view?id=1664981https://investorshangout.com/post/view?id=1664981Wed, 16 Jul 2014 11:39:34 GMTchartguy89: AMARQ 0.0073 Stock Charts $AMARQ 1 Month Chart https://investorshangout.com/post/view?id=1288111https://investorshangout.com/post/view?id=1288111Thu, 06 Mar 2014 02:13:13 GMTchartguy89: AMARQ Stock Charts Saturday, February 22, 2014 at 8:21:38 AM $AMARQ Last: -0.0052 https://investorshangout.com/post/view?id=1242733https://investorshangout.com/post/view?id=1242733Sat, 22 Feb 2014 13:21:49 GMTStockMasterTalk: The company trades publicly on the OTC markets in the U.S., and on German markets as well in the Frahttps://investorshangout.com/post/view?id=1220209https://investorshangout.com/post/view?id=1220209Mon, 10 Feb 2014 18:26:52 GMTStockMasterTalk: Following research by Hemispherx Biopharma that stated the importance in using interferons to treat https://investorshangout.com/post/view?id=1220206https://investorshangout.com/post/view?id=1220206Mon, 10 Feb 2014 18:26:19 GMTStockMasterTalk: Interferons can be used to treat several kinds of cancers, AIDS, Fibromyalgia, Multiple Sclerosis, Hhttps://investorshangout.com/post/view?id=1220198https://investorshangout.com/post/view?id=1220198Mon, 10 Feb 2014 18:24:26 GMTStockMasterTalk: $ARMAQ The company is currently seeking regulatory (FDA and others) approval of its low-dose oral ihttps://investorshangout.com/post/view?id=1220191https://investorshangout.com/post/view?id=1220191Mon, 10 Feb 2014 18:23:14 GMTStockMasterTalk: $AMARQ the market capitalization is only $395,711.https://investorshangout.com/post/view?id=1220182https://investorshangout.com/post/view?id=1220182Mon, 10 Feb 2014 18:22:03 GMTStockMasterTalk: The $AMARQ is packed full of information that you can check out here: http://www.amarbio.com/https://investorshangout.com/post/view?id=1220158https://investorshangout.com/post/view?id=1220158Mon, 10 Feb 2014 18:18:41 GMTStockMasterTalk: $AMARQ Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulatihttps://investorshangout.com/post/view?id=1220147https://investorshangout.com/post/view?id=1220147Mon, 10 Feb 2014 18:17:13 GMTStockMasterTalk: I am excited to see where this takes us! The company AMARQ holds 5 U.S. patents related to Interferohttps://investorshangout.com/post/view?id=1220126https://investorshangout.com/post/view?id=1220126Mon, 10 Feb 2014 18:14:41 GMTStockMasterTalk: It's good to see you all! How are you liking this day? $AMARQ Amarillo Biosciences is working with ghttps://investorshangout.com/post/view?id=1220105https://investorshangout.com/post/view?id=1220105Mon, 10 Feb 2014 18:11:28 GMTStockMasterTalk: $ARMAQ Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinichttps://investorshangout.com/post/view?id=1220080https://investorshangout.com/post/view?id=1220080Mon, 10 Feb 2014 18:08:06 GMTStockMasterTalk: You can check out the $AMARQ website here: http://www.amarbio.com/https://investorshangout.com/post/view?id=1220066https://investorshangout.com/post/view?id=1220066Mon, 10 Feb 2014 18:06:06 GMTStockMasterTalk: $ARMAQ GMR Data concluded that the cancer-treatment industry has sales upwards to $77.4 billion annuhttps://investorshangout.com/post/view?id=1220052https://investorshangout.com/post/view?id=1220052Mon, 10 Feb 2014 18:03:39 GMTStockMasterTalk: The company has been successful in acquiring settlements in lawsuits over their patents $AMARQhttps://investorshangout.com/post/view?id=1220041https://investorshangout.com/post/view?id=1220041Mon, 10 Feb 2014 18:01:35 GMTStockMasterTalk: You can read the current press releases for $AMARQ here: http://www.amarbio.com/news-mainmenu/currenhttps://investorshangout.com/post/view?id=1220028https://investorshangout.com/post/view?id=1220028Mon, 10 Feb 2014 17:59:45 GMTStockMasterTalk: Still bringing in the shares it looks like. Amarillo is headed by Stephen T. Chen, a doctor with ovehttps://investorshangout.com/post/view?id=1219919https://investorshangout.com/post/view?id=1219919Mon, 10 Feb 2014 17:43:38 GMTStockMasterTalk: $ARMAQ Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinichttps://investorshangout.com/post/view?id=1219835https://investorshangout.com/post/view?id=1219835Mon, 10 Feb 2014 17:20:19 GMTStockMasterTalk: The company AMARQ holds 5 U.S. patents related to Interferon usehttps://investorshangout.com/post/view?id=1219751https://investorshangout.com/post/view?id=1219751Mon, 10 Feb 2014 16:56:52 GMTStockMasterTalk: You can read the current press releases for $AMARQ here: http://www.amarbio.com/news-mainmenu/currenhttps://investorshangout.com/post/view?id=1219735https://investorshangout.com/post/view?id=1219735Mon, 10 Feb 2014 16:53:58 GMTStockMasterTalk: Man we are rocking these numbers! $ARMAQ The company is currently seeking regulatory (FDA and otherhttps://investorshangout.com/post/view?id=1219712https://investorshangout.com/post/view?id=1219712Mon, 10 Feb 2014 16:47:37 GMTStockMasterTalk: Great formations on our charts nice CMF movement and accumulation. Interferons can be used to treat https://investorshangout.com/post/view?id=1219635https://investorshangout.com/post/view?id=1219635Mon, 10 Feb 2014 16:30:40 GMTStockMasterTalk: $ARMAQ Our low-dose oral interferon has been shown to have fewer side effects and is less costly thahttps://investorshangout.com/post/view?id=1219585https://investorshangout.com/post/view?id=1219585Mon, 10 Feb 2014 16:17:30 GMTStockMasterTalk: Nice volume coming our way let's keep it up. $ARMAQ Our management team and corporate partners are whttps://investorshangout.com/post/view?id=1219477https://investorshangout.com/post/view?id=1219477Mon, 10 Feb 2014 15:57:17 GMTStockMasterTalk: Nice accumulation here. $AMARQ Amarillo Biosciences is working with global partners to conduct clinihttps://investorshangout.com/post/view?id=1219434https://investorshangout.com/post/view?id=1219434Mon, 10 Feb 2014 15:50:38 GMTStockMasterTalk: Huge cash cow potential! The $AMARQ is packed full of information that you can check out here: http:https://investorshangout.com/post/view?id=1219403https://investorshangout.com/post/view?id=1219403Mon, 10 Feb 2014 15:43:23 GMTStockMasterTalk: $AMARQ Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulatihttps://investorshangout.com/post/view?id=1219302https://investorshangout.com/post/view?id=1219302Mon, 10 Feb 2014 15:16:23 GMTStockMasterTalk: Undervalued at the moment IMO. Plenty of room to the upside and savvy traders seem to be grabbing thhttps://investorshangout.com/post/view?id=1219082https://investorshangout.com/post/view?id=1219082Mon, 10 Feb 2014 14:36:01 GMTStockMasterTalk: That resistance isn't going to hold. The $AMARQ is packed full of information that you can check outhttps://investorshangout.com/post/view?id=1219073https://investorshangout.com/post/view?id=1219073Mon, 10 Feb 2014 14:34:22 GMTStockMasterTalk: Nice beautiful day out there, and all this potential profit here - loving my day! Interferons can behttps://investorshangout.com/post/view?id=1218903https://investorshangout.com/post/view?id=1218903Mon, 10 Feb 2014 14:07:38 GMTStockMasterTalk: We have a really nice company here, and I am looking forward to what they are going to do next. $AMAhttps://investorshangout.com/post/view?id=1218891https://investorshangout.com/post/view?id=1218891Mon, 10 Feb 2014 14:05:41 GMTStockMasterTalk: Following research by Hemispherx Biopharma that stated the importance in using interferons to treat https://investorshangout.com/post/view?id=1218871https://investorshangout.com/post/view?id=1218871Mon, 10 Feb 2014 14:03:04 GMTStockMasterTalk: The company trades publicly on the OTC markets in the U.S., and on German markets as well in the Frahttps://investorshangout.com/post/view?id=1218855https://investorshangout.com/post/view?id=1218855Mon, 10 Feb 2014 14:01:37 GMTStockMasterTalk: The company has been successful in acquiring settlements in lawsuits over their patents $AMARQhttps://investorshangout.com/post/view?id=1218835https://investorshangout.com/post/view?id=1218835Mon, 10 Feb 2014 13:59:12 GMTStockMasterTalk: $AMARQ Amarillo Biosciences is working with global partners to conduct clinical studies to establishhttps://investorshangout.com/post/view?id=1218826https://investorshangout.com/post/view?id=1218826Mon, 10 Feb 2014 13:57:53 GMTStockMasterTalk: Recent data has shown that low-dose interferon-alpha (like AMARQ specializes in) can be used to reduhttps://investorshangout.com/post/view?id=1218801https://investorshangout.com/post/view?id=1218801Mon, 10 Feb 2014 13:51:26 GMTStockMasterTalk: Amarillo is headed by Stephen T. Chen, a doctor with over 30 years of experience in pharmacology. Thhttps://investorshangout.com/post/view?id=1218789https://investorshangout.com/post/view?id=1218789Mon, 10 Feb 2014 13:49:50 GMTStockMasterTalk: $ARMAQ Our management team and corporate partners are working to develop a non-toxic and inexpensivehttps://investorshangout.com/post/view?id=1218776https://investorshangout.com/post/view?id=1218776Mon, 10 Feb 2014 13:48:24 GMTStockMasterTalk: $ARMAQ GMR Data concluded that the cancer-treatment industry has sales upwards to $77.4 billion annuhttps://investorshangout.com/post/view?id=1218761https://investorshangout.com/post/view?id=1218761Mon, 10 Feb 2014 13:46:19 GMTStockMasterTalk: $ARMAQ We have license to low-dose oral interferon from Texas A&M University and agreements in phttps://investorshangout.com/post/view?id=1218741https://investorshangout.com/post/view?id=1218741Mon, 10 Feb 2014 13:44:55 GMTStockMasterTalk: $ARMAQ Our low-dose oral interferon has been shown to have fewer side effects and is less costly thahttps://investorshangout.com/post/view?id=1218730https://investorshangout.com/post/view?id=1218730Mon, 10 Feb 2014 13:43:21 GMTStockMasterTalk: $ARMAQ Amarillo Biosciences and its partners are pursuing major disease indications, with a focus onhttps://investorshangout.com/post/view?id=1218717https://investorshangout.com/post/view?id=1218717Mon, 10 Feb 2014 13:41:35 GMTStockMasterTalk: $ARMAQ Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinichttps://investorshangout.com/post/view?id=1218696https://investorshangout.com/post/view?id=1218696Mon, 10 Feb 2014 13:39:19 GMTStockMasterTalk: Seeing solid accumulation lately. Shareholders will want to lock in big profits so keep eyes peeled https://investorshangout.com/post/view?id=1218038https://investorshangout.com/post/view?id=1218038Mon, 10 Feb 2014 00:11:45 GMTStockMasterTalk: I see a lot of people scrambling to get shares on the ole L2 Recent data has shown that low-dose inhttps://investorshangout.com/post/view?id=1218034https://investorshangout.com/post/view?id=1218034Mon, 10 Feb 2014 00:09:59 GMTStockMasterTalk: We have a really nice company here, and I am looking forward to what they are going to do next. $ARMhttps://investorshangout.com/post/view?id=1218030https://investorshangout.com/post/view?id=1218030Mon, 10 Feb 2014 00:08:01 GMTStockMasterTalk: This looks awesome. $AMARQ Amarillo Biosciences is a specialty biopharmaceutical company developing https://investorshangout.com/post/view?id=1218025https://investorshangout.com/post/view?id=1218025Mon, 10 Feb 2014 00:06:06 GMTStockMasterTalk: Solid company great charts lots of promise here for sure! You can read the current press releases fohttps://investorshangout.com/post/view?id=1218021https://investorshangout.com/post/view?id=1218021Mon, 10 Feb 2014 00:04:30 GMT